Market Currents
Sanofi (SNY) and Regeneron Pharmaceuticals (REGN) announce their experimental Zaltrap drug...
-
Thursday, April 5, 2012, 6:42 AM ETSanofi (SNY) and Regeneron Pharmaceuticals (REGN) announce their experimental Zaltrap drug didn't meet targets in a late-stage Phase III trial. Despite the miss, the firms say the FDA granted a priority review to examine the proposed treatment for colon cancer.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
